CEPLENE

The mark consists of the word "CEPLENE" adjacent to a swirl design surrounding three dots.

US serial number:85021009
Application filling date:Apr. 22, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Sep. 25, 2012
Publication date:Sep. 21, 2010
Standard character claim:No
Mark drawing type:3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Goods and services:For: Pharmaceuticals, namely, compositions for the treatment of cancer International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE Basis: 1(a) First Use: Jun. 29, 2012 Use in Commerce: Jun. 29, 2012
Services:Pharmaceuticals namely compositions for the treatment of cancer
Current owner owner name:IMMUNE PHARMACEUTICALS, INC.
Current owner owner address:430 EAST 29TH STREET, SUITE 940 NEW YORK, NEW YORK UNITED STATES 10016
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:AnneMarie Kaiser
Attorney email:efiling@kmob.com
Attorney docket number:MAXIM.221T
Attorney email authorized:No
Correspondent name address:ANNEMARIE KAISER KNOBBE, MARTENS, OLSON & BEAR, LLP 2040 MAIN ST FL 14 IRVINE, CALIFORNIA UNITED STATES 92614-8214
Correspondent phone:949-760-0404
Correspondent email:efiling@kmob.com
Correspondent fax:949-760-9502
Correspondent email authorized CEPLENE:Yes

Reviews

Required fields are marked *